Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2025-12-28 @ 12:03 AM
Study NCT ID:
NCT05621434
Status:
UNKNOWN
Last Update Posted:
2022-11-18
First Post:
2022-11-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Inetetamab + Pyrotinib + Chemotherapy in Previously Untreated HER2-Positive Metastatic Breast Cancer
Sponsor:
Fujian Medical University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-10
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-09
First Submit QC Date:
None
Study First Post Date:
2022-11-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-16
Last Update Post Date:
2022-11-18
Last Update Post Date Type:
ACTUAL